Acute Porphyria Drug Database

Monograph

N06DA03 - Rivastigmine
Propably not porphyrinogenic
PNP

Rationale
Cholinesterase mediated metabolism. No data pointing to CYP-inducing properties.
Chemical description
Carbamate type of cholinesterase inhibitor used in light to moderate Alzheimer´s disease. Rapidly (t/2 60 minutes)´metabolized by cholinesterase mediated hydrolysis to the decarbamylated metabolite. CYP-metabolism probably of small importance. No data pointing to CYP-induction or inhibition.
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes N06D / N06DA or go back.
Tradenames
This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.


Exelon · Nimvastid · Prometax · Ristidic · Rivastigmine Exelon · Nimvastid · Prometax · Rivastigmin · Rivastigmine Alzerta · Alzerta Semana · Exelon · Nimvastid · Prometax · Rivanex · Rivastigmina · Rivastigmina Montvel Demelora · Exelon · Nimvastid · Rivastigmina Evertas · Exelon · Nimvastid · Ridaxin · Rivastigmina Almuriva · Alzest · Eluden · Erastig · Exelon · Kerstipon · Nimvastid · Prometax · Rivastigmine · Somniton · Voleze · Zeyzelf Exelon · Nimvastid · Prometax · Rigmin · Rivastigmin · Rivastigmine · Rivastor Exelon Atmina · Evertas · Exelon · Nimvastid · Prometax · Ristidic · Rivaldo · Rivastigmin · Rivastigmine · Rywastigmina · Rywastygmina Exelon · Nimvastid · Prometax · Rivastigmine · Werendi Exelon · Nimvastid · Prometax · Rivastigmine Exelon · Nimvastid · Prometax · Rivastigmin · Rivastigmine · Rivastor Exelon · Nimvastid · Prometax · Rivastigmine Exelon · Nimvastid · Rimpax
 
© NAPOS 2025
An unhandled error has occurred. Reload 🗙